Kingsview Wealth Management, LLC Seagen Inc. Transaction History

Kingsview Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $45,422 - $53,858	-387 Reduced 11.73%	2,911 $374,000
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $15,826 - $21,072	-117 Reduced 3.43%	3,298 $451,000
Q2 2022 Aug 16, 2022	SELL	$108.81 - $179.33 $30,466 - $50,212	-280 Reduced 7.58%	3,415 $604,000
Q1 2022 Feb 08, 2024	BUY	$119.61 - $157.85 $513,724 - $677,965	4,295 New	4,295 $618,000
Q3 2021 Dec 03, 2021	BUY	$142.45 - $169.82 $13,675 - $16,302	96 Added 2.67%	3,695 $627,000
Q2 2021 Aug 17, 2021	BUY	$135.08 - $161.1 $7,294 - $8,699	54 Added 1.52%	3,599 $570,000
Q1 2021 May 24, 2021	SELL	$137.51 - $190.8 $27,502 - $38,160	-200 Reduced 5.34%	3,545 $508,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $616,539 - $793,677	3,745 New	3,745 $656,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.